Global mRNA Vaccines Market to Reach $30.5 Billion by 2027
Amid the COVID-19 crisis, the global market for mRNA Vaccines estimated at US$ 31.9 Billion in the year 2021, is projected to reach a size of US$ 30.5 Billion by 2027, displaying at a CAGR of -0.7% over the analysis period 2021-2027.
COVID-19 Vaccine, one of the segments analyzed in the report, is projected to record a -5.9% CAGR and shrink to a market size of approximately US$ 22.2 Billion by the end of the analysis period.
After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the cancer vaccine segment is projected to spiral at 166.7% CAGR for the next 6-year period.
The U.S. Market is Estimated at $14.7 Billion, While Asia-Pacific is Forecast to Grow at 12.8% CAGR
mRNA Vaccines market in the U.S. is estimated at US$ 14.7 Billion in the year 2021. Asia-Pacific (excluding China) is forecast to reach a projected market size of US$ 3.6 Billion by the year 2027 trailing a CAGR of 12.8% over the analysis period 2021 to 2027.
Among the other noteworthy geographic markets are China and Rest of World (includes Latin America, Middle East and Africa), each forecast to grow at 10% and 4.2% respectively over the 2021-2027 period.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
mRNA Vaccines and Therapeutics Competitor Market Share Scenario Worldwide (in %): E
Global Competitor Market Shares by Segment
Standardization of Cancer Treatment (Type) Global Competitor Market Share Positioning for 2020 & 2027